Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
A dispute between the two titans in the poultry processing equipment market led the U.S. Court of Appeals for the Federal Circuit to construe the term “protection of investments” in 35 U.S.C. §252.
A dispute between the two titans in the poultry processing equipment market led the U.S. Court of Appeals for the Federal Circuit to construe the term “protection of investments” in 35 U.S.C. §252. John Bean Techs. Corp. v. Morris & Assocs., Inc., No. 2020-1090, 2021 WL 641987 (Fed. Cir. Feb. 19, 2021). This section outlines the boundaries of the court’s equitable powers to absolve liability from infringement for substantively altered patents. The court affirmed the summary judgment decision by the District Court for the Eastern District of Arkansas that granted equitable intervening rights to Morris & Associate Inc.’s (Morris) against John Bean Technologies Corporation’s (John Bean) infringement claims based on its reissued patent. Rejecting John Bean’s argument that “protection of investment” is limited to monetary investments made and recouped before the reissue certificate, the Federal Circuit determined that the lower court did not abuse its discretion by considering factors other than money invested before the reissue and granting Morris the defense of equitable intervening rights.
*May exclude premium content
By Ben Clark
United States v. Arthrex, Inc.
Proving that even the driest of constitutional issues can have significant practical effect, the U.S. Supreme Court recently heard argument in United States v. Arthrex. Before the Court was whether administrative judges of the PTAB have been appointed unconstitutionally.
By Bruce M. Wexler, Aaron P. Selikson, Ashley N. Mays-Williams and Susan S. Hwang
The decision appears to take steps to harmonize the prior cases that appropriately were guided by the Wands factors with the cases discussing the “full scope” of enablement that have engendered some confusion in the law.
By Siraj Husain
As intellectual property continues to influence business operations, more companies are considering defensive patent pools as a strategic measure to guard against threats that can stifle innovation and growth for both businesses and industries.
By Howard Shire and Shaleen J. Patel
On March 12, the Federal Circuit granted Janssen Pharmaceutica’s motion to dismiss Mylan Laboratories’ appeal and denied Mylan’s request for mandamus relief, holding that it lacked jurisdiction to hear Mylan’s appeal.